Hypertrophic Scarring After Facial Burn

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2007 by Legacy Health System.
Recruitment status was  Recruiting
Total Contact
Information provided by:
Legacy Health System
ClinicalTrials.gov Identifier:
First received: October 20, 2005
Last updated: April 10, 2007
Last verified: April 2007

Subjects with a burn to the face and/or neck will be enrolled into the study and a Three-Dimensional scanner used to see if it can objectively measure scar color and volume and measure the effect of scar on motion of the face and neck.

Condition Intervention Phase
Device: Cyberware 3030 RGB Color Scanner
Phase 2

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Official Title: Hypertrophic Scarring After Facial Burn: A Pilot, Observational Study of Static and Dynamic Measurements of Facial Scars With the 3-D Scanner Through the Scar Maturation Process

Resource links provided by NLM:

Further study details as provided by Legacy Health System:

Estimated Enrollment: 15
Study Start Date: October 2005
Estimated Study Completion Date: July 2008
Detailed Description:

Subjects will have 11 clinic visits over a 2-year period. An initial scan of the subject's head and neck will be made. Ten reproducible landmarks on the face and neck will be determined. The subject will return for follow up scans at Day 14, Day 28 and Month 2,6,9,12,18 and 24.


Ages Eligible for Study:   4 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Face and/or Neck Burn
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00242970

Contact: Lorraine Donison, RN 503 413-7945 ldonison@lhs.org

United States, Oregon
Legacy Emanuel Hospital and Health Center Recruiting
Portland, Oregon, United States, 97227
Principal Investigator: Helen Christians, OTR/L         
Sponsors and Collaborators
Legacy Health System
Total Contact
Principal Investigator: Helen Christians, ORT/L Legacy Health System
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00242970     History of Changes
Other Study ID Numbers: OBC3DS-01
Study First Received: October 20, 2005
Last Updated: April 10, 2007
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Cicatrix, Hypertrophic
Pathologic Processes

ClinicalTrials.gov processed this record on March 26, 2015